Novartis Withdraws Its Application To Extend The Marketing Authorisation For Glivec

Sat, 28 Oct 2006 05:00 PM EST

... The European Medicines Agency has been formally notified by Novartis Europharm Ltd of its decision to withdraw its application for a change to the marketing authorisation for Glivec (imatinib mesilate) 50 mg and 100 mg capsules and 100 mg and 400 mg film-coated tablets. [click link for full article] ...